Skip to content
10-Q/A

Quarterly Report

THERABIOGEN, INC.

0001393905-11-000793

← back to feed
Filed
Nov 17, 2011 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 31, 2011 44.17M sh
Operating Cash Flow Q2 2011 · Aug 31, 2011 −$392.8K
Operating Cash Flow Q2 2011 · Aug 31, 2010 −$700.22K
Cash And Equivalents Q2 2011 · Aug 31, 2011 $19.66K
Cash And Equivalents Q2 2011 · Aug 31, 2010 $50.17K
Cash And Equivalents Q2 2011 · Feb 28, 2010 $4.14K
Stockholders Equity Q2 2011 · Aug 31, 2011 $699.39K
Stockholders Equity Q2 2011 · Feb 28, 2011 $1.02M
Current Liabilities Q2 2011 · Aug 31, 2011 $1.89M
Current Liabilities Q2 2011 · Feb 28, 2011 $1.47M
Total Liabilities Q2 2011 · Aug 31, 2011 $1.9M
Total Liabilities Q2 2011 · Feb 28, 2011 $1.61M
Current Assets Q2 2011 · Aug 31, 2011 $367.13K
Current Assets Q2 2011 · Feb 28, 2011 $352.13K
Total Assets Q2 2011 · Aug 31, 2011 $2.6M
Total Assets Q2 2011 · Feb 28, 2011 $2.63M
Sga Expense Q2 2011 · Aug 31, 2011 $521.56K
Sga Expense Q2 2011 · Aug 31, 2011 $12.07M
Sga Expense Q2 2011 · Aug 31, 2010 $1.38M
Sga Expense Q2 2011 · Aug 31, 2010 $2.2M
Net Income Q2 2011 · Aug 31, 2011 −$670.96K
Net Income Q2 2011 · Aug 31, 2011 −$14.06M
Net Income Q2 2011 · Aug 31, 2010 −$2.5M
Cost Of Revenue Q2 2011 · Aug 31, 2011 $108.4K
Cost Of Revenue Q2 2011 · Aug 31, 2011 $161.26K
Revenue Q2 2011 · Aug 31, 2011 $204.91K
Revenue Q2 2011 · Aug 31, 2011 $209.12K